Casa
anatoly altura

Frontiers Case report: Short-term eculizumab use in atypical HUS

Por um escritor misterioso

Descrição
Frontiers Case report: Short-term eculizumab use in atypical HUS
Short-term use of Soliris treats two cases of aHUS not tied to mutations
Frontiers Case report: Short-term eculizumab use in atypical HUS
PDF) A systematic review on the efficacy and safety of eculizumab for atypical hemolytic uremic syndrome
Frontiers Case report: Short-term eculizumab use in atypical HUS
Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study
Frontiers Case report: Short-term eculizumab use in atypical HUS
PDF) Cost-effectiveness of eculizumab treatment after kidney transplantation in patients with atypical haemolytic uraemic syndrome
Frontiers Case report: Short-term eculizumab use in atypical HUS
Frontiers Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient
Frontiers Case report: Short-term eculizumab use in atypical HUS
Frontiers Atypical hemolytic uremic syndrome triggered by mRNA vaccination against SARS-CoV-2: Case report
Frontiers Case report: Short-term eculizumab use in atypical HUS
Eculizumab for Atypical Hemolytic–Uremic Syndrome
Frontiers Case report: Short-term eculizumab use in atypical HUS
Frontiers Case Report: Atypical HUS Presenting With Acute Rhabdomyolysis Highlights the Need for Individualized Eculizumab Dosing
Frontiers Case report: Short-term eculizumab use in atypical HUS
(PDF) Atypical Hemolytic Uremic Syndrome Post-Kidney Transplantation: Two Case Reports and Review of the Literature
Frontiers Case report: Short-term eculizumab use in atypical HUS
PDF) Atypical Hemolytic Uremic Syndrome Secondary to Lupus Nephritis, Responsive to Eculizumab
de por adulto (o preço varia de acordo com o tamanho do grupo)